共 50 条
- [31] CheckMate 331: An open-label, randomized phase III trial of nivolumab versus chemotherapy in patients (pts) with relapsed small cell lung cancer (SCLC) after first-line platinum-based chemotherapy (PT-DC).JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)Horn, LeoraReck, MartinGettinger, Scott N.Spigel, David R.Antonia, Scott JosephRupnow, Brent A.Pieters, AnneSelvaggi, GiovanniFairchild, Justin P.Peters, Solange
- [32] High fluorodeoxyglucose uptake on positron emission tomography in patients with advanced non-small cell lung cancer on platinum-based combination chemotherapyCLINICAL CANCER RESEARCH, 2006, 12 (14) : 4232 - 4236Lee, Kyung-HunLee, Se-HoonKim, Dong-WanKang, Won JunChung, June-KeyIm, Seock-AhKim, Tae-YouKim, Young WhanBang, Yung-JueHeo, Dae Seog
- [33] Serum Metabolic Profile Alteration Reveals Response to Platinum-Based Combination Chemotherapy for Lung Cancer: Sensitive Patients Distinguished from Insensitive onesScientific Reports, 7Shan XuYanping ZhouHui GengDandan SongJing TangXianmin ZhuDi YuSheng HuYanfang Cui
- [34] Serum Metabolic Profile Alteration Reveals Response to Platinum-Based Combination Chemotherapy for Lung Cancer: Sensitive Patients Distinguished from Insensitive onesSCIENTIFIC REPORTS, 2017, 7Xu, ShanZhou, YanpingGeng, HuiSong, DandanTang, JingZhu, XianminYu, DiHu, ShengCui, Yanfang
- [35] The combination therapy of anlotinib and penpulimab for the treatment of small cell lung cancer after platinum-based chemotherapy: Results of a phase II exploratory studyJOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)Yang, NongZhang, YongchangZeng, LiangYang, HaiyanZhou, ChunhuaLiu, LiXiong, YiJiang, WenjuanWang, ZhanZeng, FanxuChen, QunFeng, YuanqingZhou, ChengzhiWu, ZhijunZhang, BingLi, XiantaoXiao, MaoliangWang, Cunji
- [36] Nivolumab as maintenance therapy following platinum-based chemotherapy in non-small cell lung cancer patients after tyrosine kinase inhibitor therapy: A single-arm, open-label, phase 2 trialRESPIROLOGY, 2023, 28 : 307 - 307Kim, JiwonJi, WonjunChoi, Chang MinLee, Jae Cheol
- [37] Phase 2 multicenter trial of rucaparib and nivolumab as maintenance therapy following first-line platinum-based chemotherapy in patients with advanced biliary tract cancer (BTC): BilT-02JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)Sahai, VaibhavGriffith, Kent A.Goff, Laura WilliamsCrysler, Oxana V.Enzler, ThomasZalupski, Mark
- [38] Veliparib in Combination With Platinum-Based Chemotherapy for First-Line Treatment of Advanced Squamous Cell Lung Cancer: A Randomized, Multicenter Phase III StudyJOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (32) : 3633 - +Ramalingam, Suresh S.Novello, SilviaGuclu, Salih ZekiBentsion, DmitryZvirbule, ZaneteSzilasi, MariaBernabe, ReyesSyrigos, KonstantinosByers, Lauren AverettClingan, PhilipBar, JairVokes, Everett E.Govindan, RamaswamyDunbar, MartinAnsell, PeterHe, LeiHuang, XinSehgal, VasudhaGlasgow, JaimeeBach, Bruce A.Mazieres, Julien
- [39] Triplet Platinum-based Combination Sequential Chemotherapy Improves Survival Outcome and Quality of Life of Advanced Non-small Cell Lung Cancer PatientsASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2012, 13 (05) : 1863 - 1867Chen, Li-KunLiang, YingYang, Qun-YingXu, FeiZhou, Ning-NingXu, Guang-ChuanLiu, Guo-ZhenWei, Wei-Dong
- [40] Final results from a phase II trial of CIMAvax-EGF and nivolumab as second-line (2L) therapy after platinum-based chemotherapy in advanced non-small cell lung cancer (NSCLC).JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)Frascati, RachelEarly, Amy P.Reid, Mary E.Lee, KelvinMuhitch, JasonMesa, CirceLuaces, Patricia LorenzoSantos-Morales, OrestesDozier, AskiaPuzanov, IgorFountzilas, ChristosGandhi, ShipraAttwood, KristopherHutson, AlanJohnson, Candace S.Herrera, ZaimaSaavedra, DanayLeon, KaletRamos, Tania CrombetDy, Grace K.